Health knowledge made personal
Join this community!
› Share page:
Search posts:

Melanoma vaccine

Posted Jun 06 2009 11:16pm
In more news released from the ASCO conference:

A vaccine for advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.

The median overall survival for those receiving vaccine, 17.6 months vs. 12.8 months without the vaccine. For more details here's the news release.

Post a comment
Write a comment:

Related Searches